High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients

Cardiovascular disease (CVD), particularly atherosclerotic cardiovascular disease (ASCVD), is the leading cause of death worldwide, driven by factors like oxidative stress, inflammation, and lipid metabolism disorders. Although phenolic compounds such as Tyrosol (Tyr) and Hydroxytyrosol (HTyr) found...

Full description

Saved in:
Bibliographic Details
Main Authors: Mojgan Morvaridzadeh, Mehdi Alami, Nada Zoubdane, Hawa Sidibé, Hicham Berrougui, Tamàs Fülöp, Michel Nguyen, Abdelouahed Khalil
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/14/7/867
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849418219992907776
author Mojgan Morvaridzadeh
Mehdi Alami
Nada Zoubdane
Hawa Sidibé
Hicham Berrougui
Tamàs Fülöp
Michel Nguyen
Abdelouahed Khalil
author_facet Mojgan Morvaridzadeh
Mehdi Alami
Nada Zoubdane
Hawa Sidibé
Hicham Berrougui
Tamàs Fülöp
Michel Nguyen
Abdelouahed Khalil
author_sort Mojgan Morvaridzadeh
collection DOAJ
description Cardiovascular disease (CVD), particularly atherosclerotic cardiovascular disease (ASCVD), is the leading cause of death worldwide, driven by factors like oxidative stress, inflammation, and lipid metabolism disorders. Although phenolic compounds such as Tyrosol (Tyr) and Hydroxytyrosol (HTyr) found in extra virgin olive oil (EVOO) have shown promising antioxidant and anti-inflammatory effects, their specific roles in modulating oxidative stress biomarkers and high-density lipoprotein (HDL) functionality in elderly populations, especially in those with prior myocardial infarction, are not fully understood. This study aimed to investigate the effects of EVOO phenolic compounds on oxidative stress biomarkers and HDL functionality, and related metabolic outcomes in both healthy and post-myocardial infarction (post-MI) elderly individuals. This pilot randomized clinical trial study included healthy and post-MI participants aged 65–85 years. Participants in each group were randomly assigned to consume 25 mL per day of one of three types of olive oils: high phenolic (HTyr/Tyr) extra virgin olive oil (HP-EVOO), extra virgin olive oil (EVOO), or refined olive oil (ROO) for a period of 26 weeks. Blood samples were collected at baseline and post-intervention to assess key biomarkers. Plasma levels of (poly)phenols, malondialdehyde (MDA), total antioxidant capacity (FRAP), lecithin-cholesterol acyltransferase activity (LCAT), and serum paraoxonase-1 (PON-1) activity were measured. A total of 34 individuals completed the study (mean age: 74 years). Baseline characteristics, including sex, age, body mass index (BMI), weight, blood pressure, and inflammatory markers like C-reactive protein (CRP) levels, did not differ significantly between the two groups. A significant increase in both FRAP levels and PON-1 activity was observed in post-MI participants following HP-EVOO consumption compared to baseline (<i>p</i> = 0.014). No significant changes were observed in MDA levels, LCAT activity, or plasma (poly)phenols. These results indicate that HP-EVOO may enhance antioxidant capacity, particularly FRAP and PON-1 activity, in elderly post-MI individuals. The observed differences between groups suggest that underlying cardiometabolic status may influence the response to olive oil phenolic compounds. Further studies are needed to explore the long-term cardiovascular effects.
format Article
id doaj-art-a1c2fc17774d4d108892df90c77bd3ca
institution Kabale University
issn 2076-3921
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj-art-a1c2fc17774d4d108892df90c77bd3ca2025-08-20T03:32:31ZengMDPI AGAntioxidants2076-39212025-07-0114786710.3390/antiox14070867High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction PatientsMojgan Morvaridzadeh0Mehdi Alami1Nada Zoubdane2Hawa Sidibé3Hicham Berrougui4Tamàs Fülöp5Michel Nguyen6Abdelouahed Khalil7Geriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5H3, CanadaGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5H3, CanadaGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5H3, CanadaGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5H3, CanadaGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5H3, CanadaGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5H3, CanadaCardiology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1K 2R1, CanadaGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5H3, CanadaCardiovascular disease (CVD), particularly atherosclerotic cardiovascular disease (ASCVD), is the leading cause of death worldwide, driven by factors like oxidative stress, inflammation, and lipid metabolism disorders. Although phenolic compounds such as Tyrosol (Tyr) and Hydroxytyrosol (HTyr) found in extra virgin olive oil (EVOO) have shown promising antioxidant and anti-inflammatory effects, their specific roles in modulating oxidative stress biomarkers and high-density lipoprotein (HDL) functionality in elderly populations, especially in those with prior myocardial infarction, are not fully understood. This study aimed to investigate the effects of EVOO phenolic compounds on oxidative stress biomarkers and HDL functionality, and related metabolic outcomes in both healthy and post-myocardial infarction (post-MI) elderly individuals. This pilot randomized clinical trial study included healthy and post-MI participants aged 65–85 years. Participants in each group were randomly assigned to consume 25 mL per day of one of three types of olive oils: high phenolic (HTyr/Tyr) extra virgin olive oil (HP-EVOO), extra virgin olive oil (EVOO), or refined olive oil (ROO) for a period of 26 weeks. Blood samples were collected at baseline and post-intervention to assess key biomarkers. Plasma levels of (poly)phenols, malondialdehyde (MDA), total antioxidant capacity (FRAP), lecithin-cholesterol acyltransferase activity (LCAT), and serum paraoxonase-1 (PON-1) activity were measured. A total of 34 individuals completed the study (mean age: 74 years). Baseline characteristics, including sex, age, body mass index (BMI), weight, blood pressure, and inflammatory markers like C-reactive protein (CRP) levels, did not differ significantly between the two groups. A significant increase in both FRAP levels and PON-1 activity was observed in post-MI participants following HP-EVOO consumption compared to baseline (<i>p</i> = 0.014). No significant changes were observed in MDA levels, LCAT activity, or plasma (poly)phenols. These results indicate that HP-EVOO may enhance antioxidant capacity, particularly FRAP and PON-1 activity, in elderly post-MI individuals. The observed differences between groups suggest that underlying cardiometabolic status may influence the response to olive oil phenolic compounds. Further studies are needed to explore the long-term cardiovascular effects.https://www.mdpi.com/2076-3921/14/7/867cardiovascular diseasehydroxytyrosolextra virgin olive oiloxidative stress
spellingShingle Mojgan Morvaridzadeh
Mehdi Alami
Nada Zoubdane
Hawa Sidibé
Hicham Berrougui
Tamàs Fülöp
Michel Nguyen
Abdelouahed Khalil
High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
Antioxidants
cardiovascular disease
hydroxytyrosol
extra virgin olive oil
oxidative stress
title High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
title_full High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
title_fullStr High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
title_full_unstemmed High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
title_short High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
title_sort high tyrosol hydroxytyrosol extra virgin olive oil enhances antioxidant activity in elderly post myocardial infarction patients
topic cardiovascular disease
hydroxytyrosol
extra virgin olive oil
oxidative stress
url https://www.mdpi.com/2076-3921/14/7/867
work_keys_str_mv AT mojganmorvaridzadeh hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients
AT mehdialami hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients
AT nadazoubdane hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients
AT hawasidibe hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients
AT hichamberrougui hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients
AT tamasfulop hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients
AT michelnguyen hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients
AT abdelouahedkhalil hightyrosolhydroxytyrosolextravirginoliveoilenhancesantioxidantactivityinelderlypostmyocardialinfarctionpatients